Randomised placebo controlled trial of nebulised corticosteroids in acute respiratory syncytial viral bronchiolitis

Archives of Disease in Childhood

Volumn 82, Issue 2, 2000, Pages 126-130

  Cade, A ^a   Eglin, R ^c   Graham, M ^b   Chetcuti, A ^a   Chatrath, M ^b   Hudson, N ^d   Thomas, A ^e   Chetcuti, P A J ^a   Brownlee, K G ^b   Conway, S P ^c   Haigh, D ^d   Short, A ^e   Brown, J ^f   Dassu, D ^f   Mason, S A ^f   Phillips, A ^f  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c SEACROFT HOSPITAL   (United Kingdom)

^d ST LUKE S HOSPITAL   (United Kingdom)

^e HUDDERSFIELD ROYAL INFIRMARY   (United Kingdom)

^f Northern and Yorkshire Clinical Trials and Research Unit   (United Kingdom)

Author keywords

Acute viral bronchiolitis; Inhaled corticosteroids; Respiratory syncytial virus

Indexed keywords

BUDESONIDE; CORTICOSTEROID; PLACEBO;

ACUTE DISEASE; ARTICLE; BRONCHIOLITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEBULIZER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; STEROID THERAPY; TREATMENT OUTCOME;

ACUTE DISEASE; ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS; BRONCHIOLITIS, VIRAL; BRONCHODILATOR AGENTS; BUDESONIDE; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HOSPITALIZATION; HUMANS; INFANT; MALE; NEBULIZERS AND VAPORIZERS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

EID: 0003730615     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.82.2.126     Document Type: Article

References (28)

1. 1 McKenzie S. Respiratory tract infections. In: Forfar and Arneil's textbook of paediatrics, 4th ed. Edinburgh: Churchill Livingstone, 1992:638-40.
2. 2 Rooney JC, Williams HE, The relationship between proved viral bronchiolitis and subsequent wheezing. J Pediatr 1971;79:744-7.
3. 3 Sims DG, Downham MAPS, Gardner PS, Webb JKG, Weightman D. Study of 8-year-old children with a history of respiratory syncytial virus bronchiolitis in infancy. BMJ 1978;i:11-14.
4. 4 Stokes GM, Milner AD, Hodges IGC, Groggins RC. Lung function abnormalities after acute bronchiolitis. J Pediatr 1981;98:871-4.
5. 5 Pullan CR, Hey EN. Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy. BMJ 1982;284:1665-9.
6. 6 Murray M, Webb MSC, O'Callaghan C, Swarbrick AS, Milner AD. Respiratory status and allergy after bronchiolitis. Arch Dis Child 1992;67:482-7.
7. 7 Kuikka L, Reijonen T, Remes K, Korppi M. Bronchial asthma after early childhood wheezing: a follow-up until 4.5-6 years of age. Acta Paediatr 1994;83:744-8.
8. 8 Everard ML, Swarbrick A, Wrightman M, et al. Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection. Arch Dis Child 1994;71:428-32.
9. 9 Nahata MC, Schad PA. Pattern of drug usage in bronchiolitis. J Clin Pharm Ther 1994;19:117-18.
10. 10 Goodwin A. An uncontrolled assessment of nebulised budesonide in the treament of acute infantile bronchiolitis. British Journal of Clinical Research 1995;6:113-19.
11. 11 Reijonen T, Korppi M, Kuikka L, Remes K. Anti-inflammatory therapy reduces wheezing after bronchiolitis. Arch Pediatr Adolesc Med 1996;150:512-17.
12. 12 van Woensel JBM, Wolfs TFW, van Aalderen WMC, Brand PLP, Kimpen JLL. Randomised double blind placebo controlled trial of prednisolone in children admitted to hospital with respiratory syncytial virus bronchiolitis. Thorax 1997;52:634-7.
13. 13 Daugberg P, Brenoe E, Forchhammer H, et al. A comparison between nebulised terbutaline, nebulised cortcosteroid and systemic steroid for acute wheezing in children up to 18 months of age. Acta Paediatr 1993;82: 547-51.
14. 14 Sammartino L, Rasiah S, Wale L, Lines D. Budesonide in acute bronchiolitis. J Paediatr Child Health 1995;31:61-2.
15. 15 Richter H, Seddon P. Early nebulized budesonide in the treatment of bronchiolitis and the prevention of postbronchiolitic wheezing. J Pediatr 1998;132:849-53.
16. 16 Dabbous IA, Tkachyk JS, Stamm SJ. A double blind study on the effects of corticosteroids in the treatment of bronchiolitis. Pediatrics 1966;37:477-84.
17. 17 Leer JA, Bloomfield NJ, Green JL, et al. Corticosteroid treament in bronchiolitis. Am J Dis Child 1969;117:495-503.
18. 18 Roosevelt G, Sheehan K, Grupp-Phelan J, Tanz RR, Listernick R. Dexamethasone in bronchiolitis: a randomised controlled trial. Lancet 1996;348:292-5.
19. 19 Springer C, Bar-Yishay E, Uwayyed K, Avital A, Vilozni D, Godfrey S. Corticosteroids do not affect the clinical or physiological status of infants with bronchiolitis. Pediatr Pulmonol 1990;9:181-5.
20. 20 Klassen TP, Sutcliffe T, Watters LK, Wells GA, Allen UD, Li MM. Dexamethasone in salbutamol-treated inpatients with acute bronchiolitis: a randomized, controlled trial. J Pediatr 1997;130:191-6.
21. 21 Parmar MKB, Machin D. Survival analysis: a practical approach. London: J Wiley, 1995.
22. 22 Gardner MJ, Altman DG. Statistics with confidence. London: BMJ Publishing Group, 1989.
23. 23 Young S, O'Keeffe PT, Arnott J, Landau LI. Lung function, airway responsiveness, and respiratory symptoms before and after bronchiolitis. Arch Dis Child 1995;72:16-24.
24. 24 Martinez FD, Morgan WJ, Wright AL, Holberg C, Taussig LM. Initial airway function is a risk factor for recurrent wheezing respiratory illnesses during the first three years of life. Am Rev Respir Dis 1991;143:312-16.
25. 25 Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B, Bjorksten B. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics 1995;95: 500-5.
26. 26 Carlsen K-H, Leegaard J, Larsen S, Ørstavik I. Nebulised beclomethasone dipropionate in recurrent obstructive episodes after acute bronchiolitis. Arch Dis Child 1988; 63:1428-33.
27. 27 Wong J, Moon S, O'Callaghan C, Simpson H. Inhaled steroids reduce respiratory symptoms following bronchiolitis in infancy: a double-blind, randomised, placebo-controlled study [abstract]. Eur Resp J 1997;10(suppl 25):430S.
28. 28 Lødrup Carlsen KC, Nikander K, Carlsen K-H. How much nebulised budesonide reaches infants and toddlers? Arch Dis Child 1992;67:1077-9.